Calling the SEC By David Dayen Sep. 25 2016, 1:00

New Post Public Reply Private Reply Replies (1) Message Board
AlanC AlanC #27866
Calling the SEC

By David Dayen
Sep. 25 2016, 1:00 p.m.

(please note: The underlined words are 'clickable' links when accessed via the link at the bottom of this page)

Part 4

Penny stock gadfly Chris DiIorio tells the SEC about his suspicion that Knight Capital is tanking penny stocks on purpose and racking up unsustainable balance-sheet liabilities. But that leads to another mystery: Why don't they seem to care?

Chris DiIorio suspected major broker-dealer Knight Capital of tanking penny stocks on purpose and racking up massive, unsustainable balance-sheet liabilities based on all the stocks it “sold” that it never really had.

It had taken him five years to reach these conclusions — five years of digging through reams of financial data in search of answers to how and why his particular penny stock investment was so brutally crushed. Knight never answered DiIorio’s questions, nor, during the reporting of this story, any of The Intercept’s.


Graphic: U.S. Securities and Exchange Commission

In April 2011, DiIorio decided he had to alert the Securities and Exchange Commission. He reached out to the SEC through its Office of the Whistleblower.

“The core business at Knight has always been naked shorting penny stocks,” DiIorio asserted.

Shorting a stock is betting it will drop in price: You borrow a share, sell it, hope the stock price drops, then buy another share to pay back your loan, hopefully for less than you borrowed it for.

In naked shorting, you sell a share that doesn’t exist and cash the proceeds. Do that enough and you bet the price will drop. Set it up so that it looks like you really sold the share to everyone except an obscure middleman, and the only toxic byproduct is a liability on your balance sheet representing shares you have sold but not yet purchased.

DiIorio believed this represented the secret of Knight’s success. “I told the SEC, ‘If you don’t believe me, ask Knight!’ If their penny stock volumes went to zero, what would happen to their trading profits?”


Photo: Richard Drew/AP

DiIorio filed a TCR (tip, complaint, or referral) form. Under Section 922 of the Dodd-Frank Act, the SEC has the authority to provide substantial monetary awards to eligible whistleblowers who inform the agency of securities law violations, if the subsequent enforcement actions exceed $1 million. But DiIorio says he wasn’t trying to win back his losses by filing a whistleblower complaint; he just wanted to see the ongoing fraud of investors like him put to a stop.

He also pointed to the threat to the markets from Knight’s thinning capital compared to the billion-dollar-plus “sold not yet purchased” liability. “I said, ‘Knight is insolvent, and this is how I know.’”

Indeed, the firm’s own second-quarter 2011 report to the SEC clearly showed $1.9 billion in “sold, not yet purchased” liabilities — up from $1.3 billion just six months earlier. By contrast, it reported “net current assets, which consist of net assets readily convertible into cash less current liabilities, of $105.1 million.”

Other than a perfunctory acknowledgement of receipt, the SEC did not respond to the TCR. DiIorio sent personal emails to top officials at the agency. One still exists on the SEC’s website, an October 2011 letter to Robert Khuzami, then the SEC’s head of enforcement. “Why won’t [then-Knight CEO Thomas] Joyce disclose to the investing public the nearly [$2 billion] sold not yet purchased liability is where he moves aged fails,” DiIorio wrote. “It is a structural liability and does not in fact ‘fluctuate with volumes’ as [Joyce] has said in several public filings.”

In this case, aged fails are the obligation left over when the stock whose shares the seller was supposed to actually hand over no longer exists because of a merger or split.

SEC spokesperson Ryan White declined to comment on the matter. As a matter of policy, the SEC never confirms nor denies the existence of an investigation until it reaches the public record in a court action or administrative proceeding, and it usually doesn’t inform whistleblowers about the status of their cases unless it grants them an enforcement award.

But DiIorio grew frustrated with the lack of response. “I was baffled why the SEC was not acting on what appeared to be blatant securities violations,” he said.

What About UBS?


Photo: Jin Lee/Bloomberg/Getty Images

He used the delay, however, to clear up another nagging question: What about the other major trader in these penny stocks, the Swiss bank UBS, one of the largest private banks in the world?

Time after time, DiIorio would isolate individual penny stocks and find UBS and Knight as major traders in them. While it wasn’t possible to know for sure, the correlation suggested that UBS was repeatedly on the other side of Knight’s trades; its clients would go long while Knight’s would go short. If true, that meant UBS, or its clients, were taking on multitudes of losses by design.

Why was UBS so involved with penny stocks, which had little upside potential for a global megabank? Why was it so intertwined with Knight? Who was it purchasing these penny stocks for?

And why didn’t the bank seem to care that its clients were being sold stock that kept going down in value?

https://theintercept.com/2016/09/25/calling-the-sec/

Go CTIX!!!

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 3

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Big Screen Entertainment Group Unveils Big Screen Capital Fund

Updated Category News Views 138

Introducing Big Screen Capital Big Screen Entertainment Group (OTC:BSEG) has just announced the launch of its new funding subsidiary, Big Screen Capital. This exciting development is set to finance a range of creative projects, including the establishment of the Big Film Fund, as well as two upcoming films and advancements in medical technology. With this strategic move,...

Continue Reading
Air Products Faces Integrity Challenges: A Call for Change

Updated Category News Views 129

Understanding the Recent Calls for Change at Air Products Mantle Ridge has taken a bold step by issuing a shareholder letter that highlights critical concerns regarding Air Products and Chemicals, Inc. The organization, which owns approximately $1.3 billion in shares of Air Products, has pointed out various omissions and misleading statements from the company’s...

Continue Reading
Navigating Key Market Shifts in H2 2026: A Crucial Period

Updated Category News Views 5

The Intensity of Mid-2026: Traders Brace for Impact Traders are steeling themselves for July's rollercoaster of central bank decisions. This isn't just another season; it's a potential market earthquake. When you've got the European Central Bank, Bank of England, and Federal Reserve all signaling rate announcements within days, it's time to pay more than a little...

Continue Reading
Summary of Recent Extraordinary General Meeting Outcomes

Updated Category News Views 158

Results of Extraordinary General Meeting Announcement German High Street Properties A/S is pleased to present the results from the extraordinary general meeting that took place. This meeting marks a significant moment for the company and its shareholders as they come together to discuss essential matters affecting the company's future. Date and Purpose of the Meeting The...

Continue Reading
Tectonic Therapeutics Advances TX45 for Heart Failure Treatment

Updated Category News Views 166

Tectonic Therapeutics Advances TX45 for Heart Health Tectonic Therapeutic, Inc. (NASDAQ: TECX), an innovative biotechnology company, has announced promising outcomes from its Phase 1a trials, which could lead to significant progress in treating Group 2 Pulmonary Hypertension in patients experiencing Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The results...

Continue Reading